Avco

Finalists Named in IDC Government Insights' Fifth Annual Smart Cities North America Awards

Retrieved on: 
Monday, March 7, 2022

IDC Government Insights named finalists this week in the fifth annual Smart Cities North America Awards (SCNAA).

Key Points: 
  • IDC Government Insights named finalists this week in the fifth annual Smart Cities North America Awards (SCNAA).
  • The awards were designed to recognize the progress North American municipalities have made in executing Smart Cities projects, as well as provide a forum for sharing best practices to help accelerate Smart City development in the region.
  • As a next step in the nomination process, IDC invites the public to vote on the named finalists at https://www.surveymonkey.com/r/SCNAA22 .
  • Winners will be honored at Smart Cities Connect being held April 47 in Columbus, OH.

Avalon GloboCare to Present at the 32nd Annual ROTH Conference on March 16, 2020

Retrieved on: 
Monday, February 24, 2020

FREEHOLD, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it will present at the 32nd Annual ROTH Conference being held on March 15-17, 2020 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.

Key Points: 
  • FREEHOLD, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it will present at the 32nd Annual ROTH Conference being held on March 15-17, 2020 at The Ritz-Carlton, Laguna Niguel in Dana Point, CA.
  • David Jin, M.D., Ph.D., President and Chief Executive Officer of Avalon GloboCare is scheduled to present on Monday, March 16, at 3:30 p.m. Pacific Time.
  • The 32nd Annual ROTH Conference is scheduled for March 15-17, 2020 at The Ritz Carlton, Laguna Niguel in Orange County, CA.
  • Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics.

Restoration Builders Furthers Expansion in Texas with Latest Acquisition of AVCO Roofing

Retrieved on: 
Tuesday, January 14, 2020

SCOTTSDALE, Ariz., Jan. 14, 2020 /PRNewswire/ --Restoration Builders, Inc.("Restoration Builders" or "The Company") announced today that it has completed the asset purchase of Tyler, TX based AVCO Roofing, Inc. ("AVCO").

Key Points: 
  • SCOTTSDALE, Ariz., Jan. 14, 2020 /PRNewswire/ --Restoration Builders, Inc.("Restoration Builders" or "The Company") announced today that it has completed the asset purchase of Tyler, TX based AVCO Roofing, Inc. ("AVCO").
  • Founded in 2017 in response to the explosive growth of the $210B+ insurance restoration industry, Restoration Builders Inc. has capitalized by consolidating existing restoration and repair contractors located throughoutthe United States.
  • Heath Hicks, owner of AVCO Roofing, Inc., started in the roofing repair business when a good friend asked him to join the company he worked for.
  • "I am very proud to announce the acquisition of AVCO Roofing," said John Lorenz, Chairman and CEO of Restoration Builders, Inc. "This is an award-winning group with deep connections within their community.

Avalon GloboCare to Present at Biotech Showcase™ 2020

Retrieved on: 
Monday, January 6, 2020

FREEHOLD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced its Chief Executive Officer, Dr. David Jin, will present at the Biotech Showcase 2020 conference being held January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco, California.

Key Points: 
  • FREEHOLD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced its Chief Executive Officer, Dr. David Jin, will present at the Biotech Showcase 2020 conference being held January 13-15, 2020 at the Hilton San Francisco Union Square in San Francisco, California.
  • Registered Biotech Showcase 2020 attendees may request one-on-one meetings with Avalon through the online partneringONE system or by emailing [email protected] .
  • Qualified investors and buy- and sell-side analysts are invited to request a complimentary registration to attend Biotech Showcase and its sister event, Digital Medicine & Medtech Showcase.
  • Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative exosome technologies and cellular therapeutics.